PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
APLD vs. HALO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between APLD and HALO is 0.04, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.0

Performance

APLD vs. HALO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Applied Digital Corporation (APLD) and Halozyme Therapeutics, Inc. (HALO). The values are adjusted to include any dividend payments, if applicable.

0.00%500.00%1,000.00%1,500.00%NovemberDecember2025FebruaryMarchApril
-65.66%
1,284.00%
APLD
HALO

Key characteristics

Sharpe Ratio

APLD:

0.43

HALO:

1.28

Sortino Ratio

APLD:

1.69

HALO:

1.80

Omega Ratio

APLD:

1.20

HALO:

1.28

Calmar Ratio

APLD:

0.64

HALO:

1.43

Martin Ratio

APLD:

2.46

HALO:

4.09

Ulcer Index

APLD:

25.32%

HALO:

12.69%

Daily Std Dev

APLD:

144.02%

HALO:

40.68%

Max Drawdown

APLD:

-99.99%

HALO:

-74.26%

Current Drawdown

APLD:

-96.20%

HALO:

-9.73%

Fundamentals

Market Cap

APLD:

$916.85M

HALO:

$7.27B

EPS

APLD:

-$1.47

HALO:

$3.43

PS Ratio

APLD:

4.15

HALO:

7.16

PB Ratio

APLD:

1.70

HALO:

20.81

Total Revenue (TTM)

APLD:

$221.19M

HALO:

$819.45M

Gross Profit (TTM)

APLD:

$12.34M

HALO:

$670.60M

EBITDA (TTM)

APLD:

-$57.25M

HALO:

$530.80M

Returns By Period

In the year-to-date period, APLD achieves a -46.60% return, which is significantly lower than HALO's 23.03% return. Over the past 10 years, APLD has outperformed HALO with an annualized return of 86.43%, while HALO has yielded a comparatively lower 14.45% annualized return.


APLD

YTD

-46.60%

1M

-44.41%

6M

-49.32%

1Y

66.53%

5Y*

118.19%

10Y*

86.43%

HALO

YTD

23.03%

1M

-6.56%

6M

10.03%

1Y

53.26%

5Y*

25.41%

10Y*

14.45%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

APLD vs. HALO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

APLD
The Risk-Adjusted Performance Rank of APLD is 7878
Overall Rank
The Sharpe Ratio Rank of APLD is 7272
Sharpe Ratio Rank
The Sortino Ratio Rank of APLD is 8383
Sortino Ratio Rank
The Omega Ratio Rank of APLD is 7979
Omega Ratio Rank
The Calmar Ratio Rank of APLD is 7979
Calmar Ratio Rank
The Martin Ratio Rank of APLD is 7878
Martin Ratio Rank

HALO
The Risk-Adjusted Performance Rank of HALO is 8787
Overall Rank
The Sharpe Ratio Rank of HALO is 9090
Sharpe Ratio Rank
The Sortino Ratio Rank of HALO is 8585
Sortino Ratio Rank
The Omega Ratio Rank of HALO is 8787
Omega Ratio Rank
The Calmar Ratio Rank of HALO is 9090
Calmar Ratio Rank
The Martin Ratio Rank of HALO is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

APLD vs. HALO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Applied Digital Corporation (APLD) and Halozyme Therapeutics, Inc. (HALO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for APLD, currently valued at 0.43, compared to the broader market-2.00-1.000.001.002.003.00
APLD: 0.43
HALO: 1.28
The chart of Sortino ratio for APLD, currently valued at 1.69, compared to the broader market-6.00-4.00-2.000.002.004.00
APLD: 1.69
HALO: 1.80
The chart of Omega ratio for APLD, currently valued at 1.20, compared to the broader market0.501.001.502.00
APLD: 1.20
HALO: 1.28
The chart of Calmar ratio for APLD, currently valued at 0.68, compared to the broader market0.001.002.003.004.00
APLD: 0.68
HALO: 1.43
The chart of Martin ratio for APLD, currently valued at 2.46, compared to the broader market-5.000.005.0010.0015.0020.00
APLD: 2.46
HALO: 4.09

The current APLD Sharpe Ratio is 0.43, which is lower than the HALO Sharpe Ratio of 1.28. The chart below compares the historical Sharpe Ratios of APLD and HALO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00NovemberDecember2025FebruaryMarchApril
0.43
1.28
APLD
HALO

Dividends

APLD vs. HALO - Dividend Comparison

Neither APLD nor HALO has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

APLD vs. HALO - Drawdown Comparison

The maximum APLD drawdown since its inception was -99.99%, which is greater than HALO's maximum drawdown of -74.26%. Use the drawdown chart below to compare losses from any high point for APLD and HALO. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-86.56%
-9.73%
APLD
HALO

Volatility

APLD vs. HALO - Volatility Comparison

Applied Digital Corporation (APLD) has a higher volatility of 57.71% compared to Halozyme Therapeutics, Inc. (HALO) at 12.42%. This indicates that APLD's price experiences larger fluctuations and is considered to be riskier than HALO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%NovemberDecember2025FebruaryMarchApril
57.71%
12.42%
APLD
HALO

Financials

APLD vs. HALO - Financials Comparison

This section allows you to compare key financial metrics between Applied Digital Corporation and Halozyme Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab